Dopamine agonists increase pallidal unit activity: attenuation by agonist pretreatment and anesthesia

Intravenous administration of a single bolus dose of 1 mumol/kg of the dopamine agonists, pergolide and lisuride, caused marked increases in the unit activity of globus pallidus neurons in awake, paralyzed, locally anesthesized and artificially respired rats. These agonist effects were similar to those observed after administration of 1 mumol/kg apomorphine to awake, paralyzed rats; in rats anesthetized with chloral hydrate, however, responses to apomorphine were markedly attenuated. Subsequent administration of haloperidol reversed the effects of pergolide and pretreatment with haloperidol blocked the effects of lisuride. LSD (1 mumol/kg i.v.) did not effectively stimulate pallidal neuronal activity, suggesting that the ability to stimulate pallidal firing rates correlates better with dopamine, as opposed to serotonin, agonist potency. The ability of a non-excitatory dose of apomorphine to attenuate responses of pallidal neurons to a normally excitatory 1 mumol/kg dose of this agonist administered subsequently, was reconfirmed. Pretreatment with this 'priming' dose of apomorphine also attenuated the rate increases produced by d-amphetamine (8.7 mumol/kg) and enhanced the rate inhibitory effects of haloperidol. The 'priming' effect appears related to the dopamimetic effects of apomorphine; a non-excitatory dose of a second dopamine agonist, lisuride (0.07 mumol/kg i.v.), similarly blocked the effect of excitatory doses of lisuride (1 mumol/kg i.v.) on pallidal activity.